Literature DB >> 7964991

Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains.

M Maruno1, T Yoshimine, T Isaka, R Kuroda, H Ishii, T Hayakawa.   

Abstract

A total of 22 surgical specimens, 16 astrocytomas with various malignancy, 3 brains adjacent to tumor and 3 brains with non-neoplastic lesion, was investigated immunohistochemically for the expression of thrombomodulin (TM). This membrane protein is localized on the vascular endothelium of nearly every human tissue and plays a crucial role in the maintenance of antithrombotic property of the endothelial cells. Although the normal cerebral vessels were negative for TM, the tumor vessels were positive for TM. The increased expression of TM was, however, demonstrated not only in glioblastomas but also in low-grade astrocytomas. Furthermore, the vessels in the brains adjacent to tumor and gliotic brains were also positive for TM. Those observations suggested that the tendency of intratumoral bleeding, which is rather characteristic of glioblastomas, is not simply explained by the altered expression of vascular endothelial TM. In two cases of glioblastoma, not only the blood vessels but also the tumor cells were positive. Considering the mitogenic activity of thrombin, a ligand for TM, the increased expression of TM might be related to the tumor neovascularization and also the tumor growth.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964991     DOI: 10.1007/BF01306457

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Thrombin-mediated mitogenesis: the role of secreted protease nexin.

Authors:  J B Baker; D A Low; D L Eaton; D D Cunningham
Journal:  J Cell Physiol       Date:  1982-08       Impact factor: 6.384

2.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Authors:  C T Esmon; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

3.  The relationship between the capillary structure and hemorrhage in gliomas.

Authors:  B H Liwnicz; S Z Wu; J M Tew
Journal:  J Neurosurg       Date:  1987-04       Impact factor: 5.115

4.  Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brain.

Authors:  H Ishii; H H Salem; C E Bell; E A Laposata; P W Majerus
Journal:  Blood       Date:  1986-02       Impact factor: 22.113

5.  Distribution of the glucose transporters in human brain tumors.

Authors:  T Nishioka; Y Oda; Y Seino; T Yamamoto; N Inagaki; H Yano; H Imura; R Shigemoto; H Kikuchi
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

6.  Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture.

Authors:  K L Moore; C T Esmon; N L Esmon
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

7.  Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation.

Authors:  C T Esmon; N L Esmon; K W Harris
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

8.  Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.

Authors:  V W van Hinsbergh; R M Bertina; A van Wijngaarden; N H van Tilburg; J J Emeis; F Haverkate
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

9.  Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta.

Authors:  I Maruyama; C E Bell; P W Majerus
Journal:  J Cell Biol       Date:  1985-08       Impact factor: 10.539

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  8 in total

1.  Cellular targets of exogenous tumour necrosis factor-alpha (TNF alpha) in human gliomas.

Authors:  M Maruno; T Yoshimine; T Isaka; A Ghulam Muhammad; K Nishioka; T Hayakawa
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 2.  Models for assessment of angiogenesis in gliomas.

Authors:  R H Goldbrunner; S Wagner; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

3.  Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention?

Authors:  Ze'ev Itsekson-Hayosh; Efrat Shavit-Stein; David Last; David Goez; Dianne Daniels; Doron Bushi; Orna Gera; Zion Zibly; Yael Mardor; Joab Chapman; Sagi Harnof
Journal:  J Mol Neurosci       Date:  2015-02-19       Impact factor: 3.444

4.  Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.

Authors:  Y Zhang; H Weiler-Guettler; J Chen; O Wilhelm; Y Deng; F Qiu; K Nakagawa; M Klevesath; S Wilhelm; H Böhrer; M Nakagawa; H Graeff; E Martin; D M Stern; R D Rosenberg; R Ziegler; P P Nawroth
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

5.  Identification of novel tumor-associated cell surface sialoglycoproteins in human glioblastoma tumors using quantitative proteomics.

Authors:  François Autelitano; Denis Loyaux; Sébastien Roudières; Catherine Déon; Frédérique Guette; Philippe Fabre; Qinggong Ping; Su Wang; Romane Auvergne; Vasudeo Badarinarayana; Michael Smith; Jean-Claude Guillemot; Steven A Goldman; Sridaran Natesan; Pascual Ferrara; Paul August
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

Review 6.  Tumor angiogenesis: causes, consequences, challenges and opportunities.

Authors:  Roberta Lugano; Mohanraj Ramachandran; Anna Dimberg
Journal:  Cell Mol Life Sci       Date:  2019-11-06       Impact factor: 9.261

7.  Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT).

Authors:  Yu-Jia Chang; Ya-Wen Cheng; Ruo-Kai Lin; Chi-Chou Huang; William Tzu-Liang Chen; Tao-Wei Ke; Po-Li Wei
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

8.  CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis.

Authors:  Roberta Lugano; Kalyani Vemuri; Di Yu; Michael Bergqvist; Anja Smits; Magnus Essand; Staffan Johansson; Elisabetta Dejana; Anna Dimberg
Journal:  J Clin Invest       Date:  2018-06-25       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.